Lung Disease Clinical Trials

A listing of Lung Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4895 clinical trials
featured
Lung Nodules – Scheduled or Planned Biopsy

It's estimated that 1.5 million new cases of lung nodules are found per year in the United States. The goal in managing this condition is to rapidly identify and resect malignant nodules and avoid

  • 4 views
  • 23 Nov, 2020
  • 1 location
featured
Small cell lung cancer (SCLC) Receiving Zepzelca

People with SMALL CELL LUNG CANCER are asked to participate in a research study being conducted by Montefiore Medical Center.

lung carcinoma
  • 0 views
  • 06 Aug, 2021
  • 1 location
featured
Now Enrolling - Chronic Obstructive Pulmonary Disease (COPD) Research Study

Now Enrolling - Chronic Obstructive Pulmonary Disease (COPD) Research Study

  • 347 views
  • 20 Jul, 2021
  • 6 locations
featured
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

lung cancer
cancer
lung carcinoma
  • 92 views
  • 23 Nov, 2020
  • 1 location
featured
COPD Research Study for those with currently using inhaled medications (triple therapy) and have required an oral steroid for a flare in breathing 1-2 times in the last 12 months.

This investigational study is enrolling moderate to severe COPD subjects.   To qualify you must be on inhaled maintenance medications and have required oral steroids 1-2 times or a hospitalization in the last year.    Pulmonary function test will be performed and compensation will be provided for those who qualify.  

  • 76 views
  • 23 Nov, 2020
  • 1 location
featured
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST) (Alliance A151216)

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST) (Alliance A151216)

lung cancer
cancer
lung carcinoma
  • 72 views
  • 03 Dec, 2020
  • 1 location
featured
MS200647-0005: A Multicenter, Double Blind, Randomized, Controlled Study of M7824 with Concurrent Chemoradiation Followed by M7824 versus Concurrent Chemoradiation Plus Placebo Followed by Durvalumab in Participants with Unresectable Stage III Non-small Cell Lung Cancer

The main purpose of this study is to evaluate safety and efficacy in participants treated with concomitant chemoradiation therapy (cCRT) plus M7824 followed by M7824 compared to cCRT plus placebo followed by durvalumab.

  • 0 views
  • 31 Mar, 2021
  • 1 location
featured
  • 432 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK

crizotinib
lung cancer
lung carcinoma
  • 98 views
  • 23 Nov, 2020
  • 1 location
featured
Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)

Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)

growth factor
erlotinib
lung cancer
epidermal growth factor
lung carcinoma
  • 100 views
  • 23 Nov, 2020
  • 1 location